Patterns and Prognostic Value of Lymph Node Metastasis on Distant Metastasis and Survival in Nasopharyngeal Carcinoma: A Surveillance, Epidemiology, and End Results Study, 2006–2015

Yali Xu,Taoyuan Huang,Liqin Fan,Wei Jin,Xiaoming Chen,Jinhai Chen
DOI: https://doi.org/10.1155/2019/4094395
IF: 4.501
2019-11-29
Journal of Oncology
Abstract:This study was conducted to identify factors associated with lymph node (LN) metastasis in nasopharyngeal carcinoma (NPC) patients, analyze node distribution patterns, and explore the prognostic value of the LN metastasis level for survival. We included 2994 patients with primary NPC diagnosed between 2006 and 2015 with information in the Surveillance, Epidemiology, and End Results (SEER) database. Patients’ demographic and clinicopathologic features were compared according to LN status using chi-squared tests. The 5-year overall survival (OS) and cancer-specific survival (CSS) rates were calculated by the Kaplan–Meier method, and the differences were estimated by log-rank tests. Multivariate Cox proportional hazard models were used to evaluate independent risk factors for OS and CSS. Logistic regression was used to evaluate the risk of each LN metastasis category for distant metastasis. There were 695 patients in the N0 stage and 2299 with LN metastasis (classified as stage N1, N2, or N3). The overall incidence of LN metastasis was 76.8%. Sex and T stage were not associated with LN metastasis. Older patients had a significantly worse 5-year OS and CSS than younger patients. In terms of histologic type, keratinizing squamous cell carcinoma had the lowest 5-year OS and CSS at 48.2% and 53.8%, respectively. The most common nodal involvement level was II (65.9%), followed by III (29.1%), V (25.6%), I (17.6%), IV (15.7%), and retropharynx (13.5%). The skip metastasis rate was 5.7% (130/2299). Patients with only level II metastasis (classified as level 2) was the most common category, accounting for 30%. Compared to level 2, patients with only level I (classified as level 1) had an OR of 2.101 (95% CI: 1.090–4.047, P = 0.027 ) for distant metastasis, patients with simultaneous levels II, III, IV, and V (classified as levels 2345) had the highest OR of 4.064 (95% CI: 2.155–7.666, P < 0.001 ) for distant metastasis, and level 24 had an OR of 3.003 (95% CI: 1.074–8.395, P = 0.036 ) for distant metastasis. In survival analysis, levels 235 had a significant HR of 1.708 (95% CI: 1.089–2.678, P = 0.020 ) for CSS compared to level 2 after adjustment for age, sex, race, histology, TNM (tumor, node, and metastasis) stage, and treatment.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the incidence and pattern of lymph node metastasis (LN Metastasis) in patients with nasopharyngeal carcinoma (Nasopharyngeal Carcinoma, NPC), and to evaluate the impact of different lymph node metastasis categories on distant metastasis and survival. Specifically, the researchers hope: 1. **Identify factors related to LN metastasis**: By analyzing characteristics such as the patient's age, gender, race, histological type, TNM staging, etc., determine which factors are related to the occurrence of LN metastasis. 2. **Analyze the distribution pattern of LN metastasis**: Describe in detail the metastasis situation at different lymph node levels (such as I, II, III, IV, V and retropharyngeal), as well as the incidence of skip metastasis. 3. **Explore the prognostic value of LN metastasis categories**: Evaluate the impact of different LN metastasis categories (such as only level II, levels II and III, etc.) on distant metastasis and survival rates, especially on overall survival (Overall Survival, OS) and cancer - specific survival (Cancer - Specific Survival, CSS). ### Main research methods - **Data sources**: The study used data from 2,994 patients diagnosed with primary nasopharyngeal carcinoma between 2006 and 2015 in the SEER database. - **Statistical analysis**: - Use chi - squared tests to compare the clinicopathological characteristics of patients with and without LN metastasis. - Use the Kaplan - Meier method to calculate the 5 - year OS and CSS rates, and use log - rank tests to evaluate survival differences. - Use a multivariate Cox proportional hazards model to evaluate independent risk factors. - Use logistic regression to evaluate the risk of distant metastasis for each LN metastasis category. ### Main findings - **Incidence of LN metastasis**: Overall, 76.8% of patients had LN metastasis. - **Factors affecting LN metastasis**: - Age: Younger patients (< 40 years old) had a significantly higher LN metastasis rate than older patients. - Race: American Indians/Alaska Natives had the highest LN metastasis rate. - Histological type: Basaloid Squamous Cell Carcinoma (BSCC) had the lowest LN metastasis rate. - Gender and T - staging were not related to LN metastasis. - **Distribution pattern of LN metastasis**: - The most common metastasis level was level II (65.9%), followed by level III (29.1%), level V (25.6%), level I (17.6%), level IV (15.7%) and retropharyngeal (13.5%). - The skip metastasis rate was 5.7%. - **Impact of LN metastasis categories on distant metastasis and survival**: - Compared with only level II metastasis, the OR of distant metastasis in patients with only level I metastasis was 2.101 (95% CI: 1.090 - 4.047, P = 0.027), and the OR of distant metastasis in patients with levels II, III, IV, and V metastasis simultaneously was the highest, which was 4.064 (95% CI: 2.155 - 7.666, P < 0.001). - In the survival analysis, the HR of CSS in patients with levels II, III, and V metastasis was 1.708 (95% CI: 1.089 - 2.678, P = 0.020), which was significantly higher than that in patients with only level II metastasis. ### Conclusion The research results show that the incidence and pattern of LN metastasis in nasopharyngeal carcinoma patients are related to their age, race, histological type and M - staging, but not related to gender and T - staging. Different LN metastasis categories have a significant impact on distant metastasis and survival, especially patients with levels II, III, and V metastasis have a poorer prognosis. These findings are helpful for better understanding the role of LN metastasis in nasopharyngeal carcinoma and providing a basis for clinical treatment decisions.